3-(3-cyano-4-carboxymethyl-5-carboxy-2-thienyl)-3-azapentanedioic distrontium salt,
protelos,
S 12911,
S-12911,
S12911,
S12911-0,
S12911-2,
S12911-5,
strontium ranelate,
Strontium ranelate,
135459-87-9,
Protelos,
Distrontium renelate,
Protos,
Osseor,
UNII-04NQ160FRU,
Ranelic acid distrontium salt,
S 12911,
04NQ160FRU,
2,2'-((5-CARBOXY-4-(CARBOXYMETHYL)-3-CYANOTHIOPHEN-2-YL)AZANEDIYL)DIACETIC ACID, DISTRONTIUM SALT,
S 12911-2,
Ranelic acid strontium salt,
S-12911,
AC1OCF4B,
3-Thiopheneacetic acid, 5-(bis(carboxymethyl)amino)-2-carboxy-4-cyano-, strontium salt (1:2),
Activate As34777G5,
Strontium 2,2'-((5-carboxylato-4-(carboxylatomethyl)-3-cyanothiophen-2-yl)azanediyl)diacetate,
strontium-ranelate-protelos,
S12911,
Raneic acid, strontium salt,
C12H6N2O8S.2Sr,
SCHEMBL162654,
Strontium ranelate (Protelos),
CHEMBL3707306,
CTK8E9337,
AOB5581,
DTXSID40872400,
2196AH,
CS0039,
FK-481,
s2050,
AKOS015900462,
AKOS017344402,
DB09267,
DS-1274,
RTR-004781,
3-(3-cyano-4-carboxymethyl-5-carboxy-2-thienyl)-3-azapentanedioic distrontium salt,
KS-00000H39,
strontium 2,2'-(5-carboxylato-4-(carboxylatomethyl)-3-cyanothiophen-2-ylazanediyl)diacetate,
4CA-1180,
AK-72916,
TC-070965,
TR-004781,
FT-0658679,
S0938,
A11681,
AB01568257_01,
I14-0954,
J-006702,
S-12911-2,
5-[Bis(carboxymethyl)amino]-2-carboxy-4-cyano-3-thiopheneacetic Acid Strontium Salt,
3-Thiopheneacetic acid,5-[bis(carboxymethyl)amino]-2-carboxy-4-cyano-, strontium salt (1:2),
distrontium 5-[bis(2-oxido-2-oxoethyl)amino]-4-cyano-3-(2-oxido-2-oxoethyl)thiophene-2-carboxylate,
distrontium(2+) ion 5-[bis(carboxymethyl)amino]-3-(carboxymethyl)-4-cyanothiophene-2-carboxylate,
distrontium;5-[bis(carboxylatomethyl)amino]-3-(carboxylatomethyl)-4-cyanothiophene-2-carboxylate,
Protelos/Osseor,
C12-H10-N2-O8-S.2Sr,
ACN-034429,
CID6918182,
A8526,
C081587,
S12911-0,
S12911-2,
S12911-5,
Strontium ranelate, 98%, an antiosteoporotic agent - 10MG 10mg,